应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03681 中国抗体—B
交易中 11-19 14:52:36
1.140
-0.030
-2.56%
最高
1.150
最低
1.130
成交量
9.48万
今开
1.130
昨收
1.170
日振幅
1.71%
总市值
12.45亿
流通市值
12.45亿
总股本
10.92亿
成交额
10.75万
换手率
0.01%
流通股本
10.92亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中国抗体-B盘中异动 早盘急速拉升5.17%
市场透视 · 11-18 10:41
中国抗体-B盘中异动 早盘急速拉升5.17%
中国抗体-B(03681)股价上升6.195%,现价港币$1.2
阿斯达克财经 · 11-15
中国抗体-B(03681)股价上升6.195%,现价港币$1.2
中国抗体-B盘中异动 大幅跳水7.08%报1.050港元
市场透视 · 11-15
中国抗体-B盘中异动 大幅跳水7.08%报1.050港元
中国抗体-B股价上涨10.28% 市值涨1.32亿港元
市场透视 · 11-14
中国抗体-B股价上涨10.28% 市值涨1.32亿港元
中国抗体-B(03681)下跌11.76%,报1.05元/股
金融界 · 11-13
中国抗体-B(03681)下跌11.76%,报1.05元/股
中国抗体-B(03681)股价显著下跌11.765%,现价港币$1.05
阿斯达克财经 · 11-13
中国抗体-B(03681)股价显著下跌11.765%,现价港币$1.05
中国抗体-B盘中异动 急速下挫5.04%
市场透视 · 11-13
中国抗体-B盘中异动 急速下挫5.04%
中国抗体-B股价上涨11.67% 市值涨1.71亿港元
市场透视 · 11-12
中国抗体-B股价上涨11.67% 市值涨1.71亿港元
中国抗体-B(03681)授出1006.24万份购股权
智通财经 · 11-11
中国抗体-B(03681)授出1006.24万份购股权
中国抗体-B盘中异动 临近午盘急速下挫6.20%报1.210港元
市场透视 · 11-06
中国抗体-B盘中异动 临近午盘急速下挫6.20%报1.210港元
中国抗体-B(03681)股价显著上升12%,现价港币$1.4
阿斯达克财经 · 11-04
中国抗体-B(03681)股价显著上升12%,现价港币$1.4
中国抗体-B盘中异动 早盘股价大涨8.00%报1.350港元
市场透视 · 11-04
中国抗体-B盘中异动 早盘股价大涨8.00%报1.350港元
中国抗体-B盘中异动 快速拉升5.79%
市场透视 · 10-31
中国抗体-B盘中异动 快速拉升5.79%
中国抗体-B10月25日主力资金流出64万元 连续3日减仓
市场透视 · 10-25
中国抗体-B10月25日主力资金流出64万元 连续3日减仓
中国抗体-B10月24日遭主力抛售119万元 环比增加112.50%
市场透视 · 10-24
中国抗体-B10月24日遭主力抛售119万元 环比增加112.50%
上市公司炒股也疯狂,有公司亏完半年营收继续砸钱入市|钛媒体焦点
钛媒体APP · 10-22
上市公司炒股也疯狂,有公司亏完半年营收继续砸钱入市|钛媒体焦点
中国抗体-B盘中异动 早盘快速上涨5.84%
市场透视 · 10-16
中国抗体-B盘中异动 早盘快速上涨5.84%
中国抗体-B盘中异动 早盘快速跳水5.11%报1.300港元
市场透视 · 10-14
中国抗体-B盘中异动 早盘快速跳水5.11%报1.300港元
中国抗体-B盘中异动 早盘股价大涨6.30%报1.350港元
市场透视 · 10-10
中国抗体-B盘中异动 早盘股价大涨6.30%报1.350港元
中国抗体-B盘中异动 早盘大幅下跌6.99%报1.330港元
市场透视 · 10-08
中国抗体-B盘中异动 早盘大幅下跌6.99%报1.330港元
加载更多
公司概况
公司名称:
中国抗体—B
所属市场:
SEHK
上市日期:
--
主营业务:
中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司。该公司主要研制以单克隆抗体为基础的生物制剂和和新化学实体。该公司主要产品SM03是治疗类风湿关节炎的潜在单抗药物。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。
发行价格:
--
{"stockData":{"symbol":"03681","market":"HK","secType":"STK","nameCN":"中国抗体—B","latestPrice":1.14,"timestamp":1731999009033,"preClose":1.17,"halted":0,"volume":94800,"delay":0,"floatShares":1091755119,"shares":1091755119,"eps":-0.256807,"marketStatus":"交易中","marketStatusCode":2,"change":-0.03,"latestTime":"11-19 14:52:36","open":1.13,"high":1.15,"low":1.13,"amount":107496,"amplitude":0.017094,"askPrice":1.24,"askSize":9000,"bidPrice":1.14,"bidSize":6900,"shortable":0,"etf":0,"ttmEps":-0.20548324183042144,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732003800000},"adr":0,"listingDate":1573488000000,"adjPreClose":1.17,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":0.123521,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03681","defaultTab":"news","newsList":[{"id":"2484403660","title":"中国抗体-B盘中异动 早盘急速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484403660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484403660?lang=zh_cn&edition=full","pubTime":"2024-11-18 10:41","pubTimestamp":1731897714,"startTime":"0","endTime":"0","summary":"2024年11月18日早盘10时41分,中国抗体-B股票出现波动,股价大幅拉升5.17%。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.63%。其相关个股中,中国抗体-B、贝康医疗-B、科济药业-B涨幅较大,振幅较大的相关个股有正大企业国际、百奥赛图-B、荃信生物-B,振幅分别为15.43%、14.59%、13.77%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118104154971a709c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118104154971a709c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","03681","BK1161"],"gpt_icon":0},{"id":"2483367183","title":"中国抗体-B(03681)股价上升6.195%,现价港币$1.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2483367183","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483367183?lang=zh_cn&edition=full","pubTime":"2024-11-15 10:00","pubTimestamp":1731636000,"startTime":"0","endTime":"0","summary":"[上升股]中国抗体-B(03681) 股价在上午10:00比前收市价上升6.195%,现股价为港币$1.2。至目前为止,今日最高价为$1.2,而最低价为$1.05。总成交量为600股,总成交金额为港币$675。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241115575/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2483646113","title":"中国抗体-B盘中异动 大幅跳水7.08%报1.050港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483646113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483646113?lang=zh_cn&edition=full","pubTime":"2024-11-15 09:39","pubTimestamp":1731634762,"startTime":"0","endTime":"0","summary":"2024年11月15日早盘09时39分,中国抗体-B股票出现异动,股价快速下跌7.08%。截至发稿,该股报1.050港元/股,成交量300股,换手率0.00%,振幅0.00%。资金方面,该股资金流入315港元,流出0港元。中国抗体-B股票所在的生物技术行业中,整体涨幅为0.09%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115093922a23925c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115093922a23925c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2483893417","title":"中国抗体-B股价上涨10.28% 市值涨1.32亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483893417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483893417?lang=zh_cn&edition=full","pubTime":"2024-11-14 10:16","pubTimestamp":1731550578,"startTime":"0","endTime":"0","summary":"2024年11月14日早盘10时16分,中国抗体-B股票出现波动,股价大幅上涨10.28%。截至发稿,该股报1.180港元/股,成交量30.12万股,换手率0.03%,振幅11.21%。资金方面,该股资金流入32.8548万港元,流出2.5842万港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.65%。其相关个股中,晶泰科技、中国抗体-B、康宁杰瑞制药-B涨幅较大,振幅较大的相关个股有晶泰科技、圣诺医药-B、康宁杰瑞制药-B,振幅分别为32.92%、11.62%、9.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114101618a235adce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114101618a235adce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2483177028","title":"中国抗体-B(03681)下跌11.76%,报1.05元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483177028","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483177028?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:06","pubTimestamp":1731481560,"startTime":"0","endTime":"0","summary":"11月13日,中国抗体-B盘中下跌11.76%,截至15:06,报1.05元/股,成交102.48万元。中国抗体制药有限公司专注于研发、生产和商业化基于单克隆抗体的生物制剂来治疗免疫性疾病,其中旗舰产品SM03 是全球首款用于治疗类风湿关节炎的抗CD22单抗药物,正在全速进行商业化进程。截至2024年中报,中国抗体-B营业总收入202.6万元、净利润-9062.2万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/13150645239902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03681","BK1574","BK1161"],"gpt_icon":0},{"id":"2483028725","title":"中国抗体-B(03681)股价显著下跌11.765%,现价港币$1.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2483028725","media":"阿斯达克财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483028725?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:03","pubTimestamp":1731481380,"startTime":"0","endTime":"0","summary":"[下跌股]中国抗体-B(03681) 股价在下午03:03比前收市价显著下跌11.765%,现股价为港币$1.05。至目前为止,今日最高价为$1.19,而最低价为$1.05。总成交量为22.71万股,总成交金额为港币$25.884万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2411131812/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2483704097","title":"中国抗体-B盘中异动 急速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483704097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483704097?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:01","pubTimestamp":1731481281,"startTime":"0","endTime":"0","summary":"2024年11月13日下午盘15时01分,中国抗体-B股票出现异动,股价快速下跌5.04%。截至发稿,该股报1.130港元/股,成交量15.48万股,换手率0.01%,振幅5.04%。中国抗体-B股票所在的生物技术行业中,整体跌幅为2.01%。其相关个股中,正大企业国际、腾盛博药-B、贝康医疗-B涨幅较大,振幅较大的相关个股有宜明昂科-B、正大企业国际、科济药业-B,振幅分别为23.63%、20.75%、14.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113150121971a637f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113150121971a637f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","03681","BK1574"],"gpt_icon":0},{"id":"2482982797","title":"中国抗体-B股价上涨11.67% 市值涨1.71亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482982797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482982797?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:47","pubTimestamp":1731376048,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘09时47分,中国抗体-B股票出现波动,股价急速拉升11.67%。截至发稿,该股报1.340港元/股,成交量300股,换手率0.00%,振幅0.00%。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,瑞科生物-B、三叶草生物-B、药明合联涨幅较大,振幅较大的相关个股有绿竹生物-B、和誉-B、三叶草生物-B,振幅分别为18.42%、12.23%、11.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111209472898e41ecf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111209472898e41ecf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","03681"],"gpt_icon":0},{"id":"2482946270","title":"中国抗体-B(03681)授出1006.24万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2482946270","media":"智通财经","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482946270?lang=zh_cn&edition=full","pubTime":"2024-11-11 17:15","pubTimestamp":1731316539,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国抗体-B(03681)发布公告,于2024年11月11日,公司已根据其购股权计划向王善春先生,一名执行董事授出1006.24万份购股权,以供认购合共1006.24万股公司新股份,但须待承授人接纳后方可作实。购股权的行使价为每股1.256港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03681","BK1574","BK1161"],"gpt_icon":0},{"id":"2481822616","title":"中国抗体-B盘中异动 临近午盘急速下挫6.20%报1.210港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481822616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481822616?lang=zh_cn&edition=full","pubTime":"2024-11-06 11:54","pubTimestamp":1730865274,"startTime":"0","endTime":"0","summary":"2024年11月06日临近午盘11时54分,中国抗体-B股票出现波动,股价大幅下挫6.20%。截至发稿,该股报1.210港元/股,成交量57.51万股,换手率0.05%,振幅6.98%。资金方面,该股资金流入771港元,流出70.9113万港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.13%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106115434aba41665&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106115434aba41665&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","03681","BK1161"],"gpt_icon":0},{"id":"2480344369","title":"中国抗体-B(03681)股价显著上升12%,现价港币$1.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2480344369","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480344369?lang=zh_cn&edition=full","pubTime":"2024-11-04 11:24","pubTimestamp":1730690640,"startTime":"0","endTime":"0","summary":"[上升股]中国抗体-B(03681) 股价在上午11:24比前收市价显著上升12%,现股价为港币$1.4。至目前为止,今日最高价为$1.4,而最低价为$1.25。总成交量为33.36万股,总成交金额为港币$45.601万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241104878/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03681","BK1161","BK1574"],"gpt_icon":0},{"id":"2480341669","title":"中国抗体-B盘中异动 早盘股价大涨8.00%报1.350港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480341669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480341669?lang=zh_cn&edition=full","pubTime":"2024-11-04 11:23","pubTimestamp":1730690628,"startTime":"0","endTime":"0","summary":"2024年11月04日早盘11时23分,中国抗体-B股票出现异动,股价急速拉升8.00%。截至发稿,该股报1.350港元/股,成交量10.17万股,换手率0.01%,振幅8.00%。资金方面,该股资金流入7.8015万港元,流出5.3334万港元。中国抗体-B股票所在的生物技术行业中,整体涨幅为0.17%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110411234898e40316&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110411234898e40316&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","03681","BK1161"],"gpt_icon":0},{"id":"2479717278","title":"中国抗体-B盘中异动 快速拉升5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479717278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479717278?lang=zh_cn&edition=full","pubTime":"2024-10-31 10:53","pubTimestamp":1730343214,"startTime":"0","endTime":"0","summary":"2024年10月31日早盘10时53分,中国抗体-B股票出现异动,股价大幅上涨5.79%。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.44%。其相关个股中,华昊中天医药-B、中生北控生物科技、中国抗体-B涨幅较大,振幅较大的相关个股有中生北控生物科技、华昊中天医药-B、方达控股,振幅分别为100.00%、37.19%、10.98%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103110533498e3f969&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103110533498e3f969&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03681","BK1161","BK1574"],"gpt_icon":0},{"id":"2478567739","title":"中国抗体-B10月25日主力资金流出64万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2478567739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478567739?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:15","pubTimestamp":1729844136,"startTime":"0","endTime":"0","summary":"10月25日, 中国抗体-B股价涨2.24%,报收1.37元,成交金额72万元,换手率0.05%,振幅2.99%,量比1.12。中国抗体-B今日主力资金净流出64万元,连续3日净流出,上一交易日主力净流出119万元,今日环比减少46.22%。该股近5个交易日下跌2.16%,主力资金累计净流出238万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出616万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025161551ab72e9f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025161551ab72e9f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03681","BK1574","BK1161"],"gpt_icon":0},{"id":"2477577484","title":"中国抗体-B10月24日遭主力抛售119万元 环比增加112.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477577484","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477577484?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:15","pubTimestamp":1729757754,"startTime":"0","endTime":"0","summary":"10月24日, 中国抗体-B股价跌2.19%,报收1.34元,成交金额150万元,换手率0.10%,振幅2.19%,量比2.89。中国抗体-B今日主力资金净流出119万元,上一交易日主力净流出56万元,今日环比增加112.50%。该股近5个交易日下跌0.74%,主力资金累计净流出174万元;近20日主力资金累计净流出576万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024161606a1e64800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024161606a1e64800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","03681"],"gpt_icon":0},{"id":"2477871211","title":"上市公司炒股也疯狂,有公司亏完半年营收继续砸钱入市|钛媒体焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=2477871211","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477871211?lang=zh_cn&edition=full","pubTime":"2024-10-22 13:52","pubTimestamp":1729576327,"startTime":"0","endTime":"0","summary":"近来的A股行情火爆,散户跑步入市,一同抱钱杀入的还有中国A股上市公司。10月19日,新城市(300778.SZ)、中兴商业(000715.SZ)双双公告拟进行证券投资,前者额度是不超过2亿元,后者则是在2023年12月5000万元额度上追加了7000万元资金。钛媒体APP梳理发现,始于国庆前的一波行情直接将市场预期拉满,上市公司入市的热情明...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OrPMIO0832E9eSbP46Qw9ugMfWKe1iyRWz58dp9HMQCl0AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OrPMIO0832E9eSbP46Qw9ugMfWKe1iyRWz58dp9HMQCl0AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241022A04MAX00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241022A04MAX00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1502","LU1023057109.AUD","LU2097828714.EUR","BK1575","LU0611395673.USD","LU2097828557.USD","BK1191","LU0417516902.SGD","LU2097828474.EUR","LU1328277881.USD","BK1523","BK1574","81810","LU1813983027.USD","BK1589","LU0348827113.USD","SG9999002463.SGD","LU0359201885.HKD","LU1770036033.HKD","03681","LU0314109678.HKD","BK1161","LU0345775950.USD","02633","BK1193","BK1506","LU0345776255.USD","BK1521","LU0359201612.USD","LU0348825331.USD","LU1770034418.SGD","LU2039709279.SGD","LU2097828631.EUR","LU0561508036.HKD","BK1606","LU0359202008.SGD","BK1607","LU2097828805.USD","02161"],"gpt_icon":1},{"id":"2475623016","title":"中国抗体-B盘中异动 早盘快速上涨5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475623016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475623016?lang=zh_cn&edition=full","pubTime":"2024-10-16 09:42","pubTimestamp":1729042952,"startTime":"0","endTime":"0","summary":"2024年10月16日早盘09时42分,中国抗体-B股票出现波动,股价急速上涨5.84%。中国抗体-B股票所在的生物技术行业中,整体跌幅为0.59%。其相关个股中,宜明昂科-B、再鼎医药、科笛-B涨幅较大,振幅较大的相关个股有科笛-B、康诺亚-B、宜明昂科-B,振幅分别为8.50%、7.02%、6.08%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016094232971a080e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016094232971a080e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","03681","BK1161"],"gpt_icon":0},{"id":"2475055308","title":"中国抗体-B盘中异动 早盘快速跳水5.11%报1.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475055308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475055308?lang=zh_cn&edition=full","pubTime":"2024-10-14 09:35","pubTimestamp":1728869716,"startTime":"0","endTime":"0","summary":"2024年10月14日早盘09时35分,中国抗体-B股票出现波动,股价快速跳水5.11%。截至发稿,该股报1.300港元/股,成交量300股,换手率0.00%,振幅0.00%。资金方面,该股资金流入0港元,流出390港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为1.15%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101409351698e3c155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101409351698e3c155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","03681","BK1161"],"gpt_icon":0},{"id":"2474739119","title":"中国抗体-B盘中异动 早盘股价大涨6.30%报1.350港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474739119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474739119?lang=zh_cn&edition=full","pubTime":"2024-10-10 09:41","pubTimestamp":1728524473,"startTime":"0","endTime":"0","summary":"2024年10月10日早盘09时41分,中国抗体-B股票出现异动,股价大幅拉升6.30%。截至发稿,该股报1.350港元/股,成交量600股,换手率0.00%,振幅2.36%。资金方面,该股资金流入408港元,流出0港元。中国抗体-B股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,康希诺生物、中国抗体-B、诺诚健华涨幅较大,振幅较大的相关个股有乐普生物-B、创胜集团-B、科笛-B,振幅分别为12.29%、10.53%、8.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101009411398e3b936&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101009411398e3b936&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03681","BK1161","BK1574"],"gpt_icon":0},{"id":"2473450456","title":"中国抗体-B盘中异动 早盘大幅下跌6.99%报1.330港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473450456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473450456?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:43","pubTimestamp":1728351815,"startTime":"0","endTime":"0","summary":"2024年10月08日早盘09时43分,中国抗体-B股票出现异动,股价大幅跳水6.99%。截至发稿,该股报1.330港元/股,成交量37.83万股,换手率0.03%,振幅8.39%。资金方面,该股资金流入432港元,流出53.0721万港元。中国抗体-B股票所在的生物技术行业中,整体跌幅为1.82%。中国抗体-B公司简介:中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的中国香港生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080943359719ec88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080943359719ec88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","03681"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinomab.com","stockEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.1583},{"period":"3month","weight":-0.0787},{"period":"6month","weight":-0.3676},{"period":"1year","weight":0.0174},{"period":"ytd","weight":-0.3036}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国抗体制药有限公司是一家主要研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司。该公司主要研制以单克隆抗体为基础的生物制剂和和新化学实体。该公司主要产品SM03是治疗类风湿关节炎的潜在单抗药物。该公司研发药物用于治疗类风湿关节炎、系统性红斑狼疮、哮喘、天疱疮、干燥综合症及其他免疫性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.013788},{"month":2,"riseRate":0.2,"avgChangeRate":-0.060562},{"month":3,"riseRate":0.2,"avgChangeRate":-0.049178},{"month":4,"riseRate":0.8,"avgChangeRate":0.04218},{"month":5,"riseRate":0.2,"avgChangeRate":0.013437},{"month":6,"riseRate":0.2,"avgChangeRate":-0.022623},{"month":7,"riseRate":0.2,"avgChangeRate":-0.070691},{"month":8,"riseRate":0.2,"avgChangeRate":-0.116108},{"month":9,"riseRate":0.4,"avgChangeRate":-0.010658},{"month":10,"riseRate":0,"avgChangeRate":-0.065544},{"month":11,"riseRate":0.8,"avgChangeRate":0.025367},{"month":12,"riseRate":0.4,"avgChangeRate":0.133947}],"exchange":"SEHK","name":"中国抗体—B","nameEN":"SINOMAB BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国抗体—B(03681)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国抗体—B(03681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国抗体—B,03681,中国抗体—B股票,中国抗体—B股票老虎,中国抗体—B股票老虎国际,中国抗体—B行情,中国抗体—B股票行情,中国抗体—B股价,中国抗体—B股市,中国抗体—B股票价格,中国抗体—B股票交易,中国抗体—B股票购买,中国抗体—B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国抗体—B(03681)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国抗体—B(03681)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}